Resveratrol in Patients with Minimal Hepatic Encephalopathy.

about

D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis Effects of Polyphenol-Rich Foods on Human Health

P2860

Q57484445-910B5FF2-A459-45A2-A8A5-9DCB35FB47AA Q58780361-4C1C503D-6069-4BA6-8963-6B5123ADBDAC

P2860

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

Item

http://www.wikidata.org/entity/Q53438002

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

@en

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

@nl

type

Item

label

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

@en

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

@nl

prefLabel

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

@en

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

@nl

P1476

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

@en

P2093

Enzo Vicari

http://www.w3.org/2001/XMLSchema#string

Filippo Drago

http://www.w3.org/2001/XMLSchema#string

Giulia Malaguarnera

http://www.w3.org/2001/XMLSchema#string

Massimo Motta

http://www.w3.org/2001/XMLSchema#string

Rita Bella

http://www.w3.org/2001/XMLSchema#string

P2860

Dopaminergic agonists for hepatic encephalopathy

The molecular neurobiology of depression

Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

Neuropsychological characterization of hepatic encephalopathy

Effects of pterostilbene and resveratrol on brain and behavior

The anaplerotic flux and ammonia detoxification in hepatic encephalopathy.

L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin.

Hepatitis C virus infection: quality of life and side effects of treatment.

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

P31

scholarly article

P356

10.3390/NU10030329

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29522439

http://www.w3.org/2001/XMLSchema#string

P932

5872747

http://www.w3.org/2001/XMLSchema#string

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

about

P2860

P2860

Resveratrol in Patients with Minimal Hepatic Encephalopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932